New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

Updated November 23rd, 2021

New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

RET+ lung cancers are aggressive and have a poor prognosis, but new targeted drug selpercatinib (Retevmo) benefits more than 90% of patients who have this type of cancer.

NOW
PLAYING
Are the Treatments the Same for a Second or Third Relapse of Multiple Myeloma?
NOW
PLAYING
Induction Therapy for Multiple Myeloma: Is the Four-Drug Combination Better Than the Three-Drug Combination?
NOW
PLAYING
How Does FISH Testing Help Decide the Course of Treatment for Multiple Myeloma?
NOW
PLAYING
What It's Like to Take Revlimid for Multiple Myeloma
NOW
PLAYING
How Do I Get Induction Therapy?
NOW
PLAYING
What Is the Maintenance Phase of Multiple Myeloma Treatment?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.